Answers are grounded in this paper and cite their sources.
History, clinical examination, and relevant investigations A 34-year-old right-handed man, cab driver by occupation, recently diagnosed with a case of the human immunodeficiency virus (HIV) infection, has presented with 12 months history of progressive forgetfulness, difficulty in driving and change in behavior in the form of irritability, and reduced interaction to surroundings. There is no history of fever, headache, vomiting, or seizure. His general examination is normal. On nervous system examination, cognitive assessment reveals reduced attention, poor memory, and executive dysfunction with calculation and naming difficulty. His rest of the neurological, neuro-ophthalmological, and other system examinations are normal. His routine biochemical examination is unremarkable and his CD4 count is 256. His cerebrospinal fluid (CSF) examination revealed nil cells, glucose, 79 mg/dl, and protein of 56 mg/dl. CSF Gram stain, culture, acid-fast bacilli stain, fungal stain, Indian ink preparation, and viral serology panel are negative. A magnetic resonance imaging (MRI) brain was done and the fluid-attenuated inversion recovery (FLAIR) sequence is shown in Figure 1.Figure 1: MRI brain FLAIR image showing symmetrical hyperintensities in bilateral frontal region (red arrow) with sparing of subcortical U-fibers (blue arrow). MRI = Magnetic resonance imaging, FLAIR = Fluid-attenuated inversion recoveryWhat is the possible diagnosis? Considering the clinical scenario and MRI images, a primary diagnosis of HIV-associated neurocognitive disorder (HAND) is made. His MRI brain image is showing symmetrical T2 FLAIR hyperintensities in the bilateral frontal region with typical sparing of subcortical U-fibers classically seen in HIV-associated dementia (HAD).[1] Short review of human immunodeficiency virus-associated neurocognitive disorder hIV can enter the central nervous system (CNS) early in the course of the disease and can lead to various important CNS conditions, such as HIV encephalopathy and HAND.[2] Neurocognitive disorders in HIV without any other obvious secondary cause have been classified as HAND which include three conditions: asymptomatic neurocognitive impairment, HIV-associated mild neurocognitive disorder, and HAD. This current terminology of HAND and its subclassifications was first proposed at the Frascati conference in 2004.[3] The cognitive decline in milder presentations of HAND is generally very slow and includes attention deficits, working memory impairment, executive dysfunction, and delayed information processing speed. HAND develops in patients with normal CD4 counts.[4] There are no specific imaging findings. The presentation of HAD is typically subacute and may remain stable for years.[5] HAD occurs predominantly in untreated HIV patients with high viral loads and CD4 counts <200. It is primarily characterized by subcortical dementia, with attention-concentration impairment, impaired psychomotor speed, and precision.[6] In patients with HIV dementia, CSF picture can be acellular, although, in 25% of cases, a mononuclear pleocytosis is found. Elevated protein (60%) and immunoglobulin G are also reported. Sometimes oligoclonal bands are found to be present. CSF study helps in ruling out other opportunistic infections in HIV, such as cryptococcal infections and varicella-zoster viruses. In any case of relatively new-onset cognitive decline, specifically in patients of HIV, reversible causes need to be always searched for in detail so that treatment can be targeted accordingly. Neuroimaging of the brain helps in diagnosing the severity of the HAND spectrum and ruling out the other possible etiologies of cognitive decline. Computed tomography (CT) scan of the brain is used as a primary screening imaging to look for any evidence of ring-enhancing lesions or cerebral edema or chronic subdural hemorrhage or any other specific pattern of cerebral atrophy. CT brain imaging findings in HAD include diffuse and symmetric cerebral atrophy, out of proportion to the age of the patient, and symmetric periventricular and deep white matter hypoattenuation. MRI brain tends to have symmetric periventricular and deep white matter T2/FLAIR hyperintensity with relative sparing of the subcortical white matter and posterior fossa structures. It can be confluent or patchy without any mass effect or enhancement.[1] Among the other differentials of HAD, progressive multifocal leukoencephalopathy (PML) typically presents as multifocal, asymmetric periventricular, and subcortical involvement. There is little or no mass effect or enhancement[7] and the subcortical U-fibers are commonly involved with a predilection for the parieto-occipital regions. The lesion presents as a sharply demarcated peripheral border along the subcortical U-fibers and a hazy and ill-defined inner border.[8] The corpus callosum may also be involved. HAD should always be differentiated from PML considering the poorer prognosis in the latter one. On contrary, HAD is prognostically better after early diagnosis and prompt treatment with combination antiretroviral therapy (ART). Other possible differential diagnosis of HAD apart from PML is leukodystrophies, leukoaraiosis, cerebral autosomal dominant arteriopathy with subcortical infarcts, and leukoencephalopathy, primary demyelinating CNS diseases such as multiple sclerosis, posterior reversible encephalopathy syndrome, acute disseminated encephalomyelitis, cerebral toxoplasmosis, and immunodeficiency-associated primary CNS lymphoma. MRI brain is an important investigation in the setting of HIV to look for any evidence of the above conditions as per their characteristic MRI brain appearances. With the introduction and widespread application of combination ART, there has been a decrease in the prevalence of more severe neurocognitive deficits (i.e., HAD),[9] although milder cognitive deficits without alternative explanation are still common in the setting of HIV which may at times remain undiagnosed initially. Therefore, as per the MRI appearance found in our patient and evidence from the available literature, it can be commented that MR imaging brain is an effective investigation in the setting of cognitive decline in HIV. It helps in the exclusion of the other possible secondary etiologies and is also very much useful to differentiate PML from HAND in patients of HIV. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understand that name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Bhowmik et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: